title: Lymphocytes from bipolar and schizophrenic patients share common biochemical markers related to histone synthesis and histone cell membrane localization characteristic of an activated state.
abstract: In a previous communication, based on the total histone and histone variants' synthesis rates, biochemical parameters used for the characterization of the activation state of lymphocytes, we showed that a portion of the lymphocyte population obtained from peripheral blood of patients with bipolar disorder in the manic and/or depressed phases of the illness were in an activated state as opposed to normothymic patients and control subjects whose lymphocytes are in a resting, Go, state. In light of these previous findings, in the present investigation, we have analyzed total histone synthesis rates and the H2A and H3 histone variants' synthesis pattern of acid-extracted histones from the lymphocytes' nuclear fraction obtained from control subjects, patients with bipolar disorder in all phases of the illness, and patients with schizophrenia. Additional biochemical parameters, such as total cellular protein and DNA synthesis rates, were also studied. Moreover, recent findings from other investigators showed the association of histones on the plasma membrane fraction of PHA-activated, but not Go resting lymphocytes. Based on these results, acid-extracted proteins from the plasma membrane fraction obtained from control, bipolar patients in all phases of the illness, and schizophrenic patients were analyzed by immunoblotting using a polyclonal histone antibody, anti-H2B. All biochemical parameters tested show that a portion of the lymphocyte population from bipolar, i.e. manic and depressive, as well as schizophrenic patients are in an activated state and clearly indicate that the unusual for lymphocytes cell cycle-related histone biochemical properties are common to both disorders.
authors.affiliation: National Centre for Scientific Research DEMOKRITOS, Institute of Biology, Athens, Greece. sourlin@mail.demokritos.gr
authors.forename: Thomae G
authors.initials: TG
authors.lastname: Sourlingas
authors.forename: Marietta R
authors.initials: MR
authors.lastname: Issidorides
authors.forename: Basil
authors.initials: B
authors.lastname: Alevizos
authors.forename: Vassilis P
authors.initials: VP
authors.lastname: Kontaxakis
authors.forename: Margarita
authors.initials: M
authors.lastname: Chrysanthou-Piterou
authors.forename: Evangelia
authors.initials: E
authors.lastname: Livaniou
authors.forename: Angeliki P
authors.initials: AP
authors.lastname: Karpouza
authors.forename: Kalliope E
authors.initials: KE
authors.lastname: Sekeri-Pataryas
mesh_terms: D000328:Adult; D015415:Biomarkers; D001714:Bipolar Disorder / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004587:Electrophoresis, Agar Gel; D005260:Female; D006657:Histones / Q000096:biosynthesis*; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism* / Q000473:pathology; D008297:Male; D012559:Schizophrenia / Q000097:blood / Q000235:genetics / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D006657:Histones; D004247:DNA